Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Breast Neoplasms 304Carcinoma, Non-Small-Cell Lung 182Ovarian Neoplasms 154Lung Neoplasms 92Esophageal Neoplasms 75Triple Negative Breast Neoplasms 71Stomach Neoplasms 71Fallopian Tube Neoplasms 68Squamous Cell Carcinoma of Head and Neck 51Esophageal Squamous Cell Carcinoma 50Neoplasm Metastasis 48Neoplasms 45Endometrial Neoplasms 42Head and Neck Neoplasms 41Carcinoma, Ovarian Epithelial 41Uterine Cervical Neoplasms 37Recurrence 26Carcinoma, Squamous Cell 23Adenocarcinoma Of Esophagus 22Urinary Bladder Neoplasms 19Melanoma 19Inflammatory Breast Neoplasms 19Prostatic Neoplasms 18Adenocarcinoma of Lung 17Carcinoma 15Breast Neoplasms, Male 15Unspecified Adult Solid Tumor, Protocol Specific 14Testicular Neoplasms 13Small Cell Lung Carcinoma 12Peritoneal Neoplasms 12

Interventions

Cisplatin 9Cetuximab 9Radiotherapy, Intensity-Modulated 7Everolimus 4Docetaxel 3Carboplatin 3Biopsy 3130-nm albumin-bound paclitaxel 3Ultrasonography 2Taxes 2Radiotherapy 2Radiation 2Photochemotherapy 2Paclitaxel 2Microarray Analysis 2Immunohistochemistry 2Gene Expression Profiling 2Fluorouracil 2Erlotinib Hydrochloride 2Cryosurgery 2Albumin-Bound Paclitaxel 21-phenyl-3,3-dimethyltriazene 2temoporfin 1talactoferrin alfa 1sargramostim 1pimonidazole 1pembrolizumab 1Zinc Oxide 1X-Rays 1Vaccinium myrtillus extract 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Tongue Neoplasms × Paclitaxel × Clear all
NCT01316757 2018-02-26

Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer

Fox Chase Cancer Center

Phase 2 Completed
24 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Salivary Gland Neoplasms, Tongue Neoplasms

NCT01333085 2016-02-10

CAPRA

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 1/2 Completed
49 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡